AdvanSix (ASIX) revenue breakdown
By product, Plant Nutrients is the largest at 37% of fiscal 2025 revenue; Chemical Intermediates grew fastest, 0% a year over 6 years.
By region, United States is the largest at 86% of fiscal 2025 revenue, growing 3% a year over 9 years.
Revenue by product
Fiscal years, as AdvanSix reports them in its 10-K filings; fiscal 2025 total $1.5B.
| Products | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| Plant Nutrients | — | — | — | $658M | $478M | $458M | $564M | 37% |
| Chemical Intermediates | $368M | $369M | $545M | $483M | $401M | $435M | $377M | 25% |
| Nylon | $351M | $285M | $423M | $485M | $357M | $349M | $310M | 20% |
| Caprolactam | $279M | $216M | $316M | $320M | $298M | $276M | $271M | 18% |
| Ammonium Sulfate | $299M | $288M | $401M | — | — | — | — | — |
Revenue by region
Fiscal years, as AdvanSix reports them in its 10-K filings; fiscal 2025 total $1.5B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $976M | $1.2B | $1.3B | $1.1B | $891M | $1.4B | $1.6B | $1.3B | $1.3B | $1.3B | 86% |
| International | $216M | $286M | $244M | $240M | $267M | $302M | $323M | $284M | $213M | $212M | 14% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ASIX.
Open ASIX in InvestinglyQuestions
Where does AdvanSix make its money?
In fiscal 2025, by product: Plant Nutrients $564M, Chemical Intermediates $377M, Nylon $310M, Caprolactam $271M.
From AdvanSix's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.